MDS-1497: Primary Analysis of the Randomized, Phase 3 VERONA Study of Venetoclax With Azacitidine Versus Placebo With Azacitidine in Patients With Treatment-Naïve, Intermediate and Higher-Risk Myelodysplastic Syndromes

Guillermo Garcia‐Manero, Uwe Platzbecker, Pierre Fenaux, Gail J. Roboz, Chun Yew Fong, Marek Hus, Robert Delage, Andrew M. Brunner, Je‐Hwan Lee, Mehmet Turgut, Dominiek Mazure, Yin‐Hsun Feng, Yasushi Miyazaki, Zdeněk Kořı́stek, Sophie Dimicoli‐Salazar, María Díez‐Campelo, David Lavie, Dominic Culligan, Grace Ku, Zhijian Xiao, Fang Fang, Maggie Headley, Jalaja Potluri, Amer M. Zeidan, Jacqueline S. Garcia